BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ahmad F, Kannan M, Ansari AW. Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism. Cytokine Growth Factor Rev 2021:S1359-6101(21)00079-4. [PMID: 34750061 DOI: 10.1016/j.cytogfr.2021.10.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen J, Gao X, Shen S, Xu J, Sun Z, Lin R, Dai Z, Su L, Christiani DC, Chen F, Zhang R, Wei Y. Association of longitudinal platelet count trajectory with ICU mortality: A multi-cohort study. Front Immunol 2022;13:936662. [DOI: 10.3389/fimmu.2022.936662] [Reference Citation Analysis]
2 Gupta A, Qaisar R, Halwani R, Kannan M, Ahmad F. TFPI and FXIII negatively and S100A8/A9 and Cystatin C positively correlate with D-dimer in COVID-19. Exp Biol Med (Maywood) 2022;:15353702221102117. [PMID: 35723053 DOI: 10.1177/15353702221102117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Gupta A, Jayakumar MN, Saleh MA, Kannan M, Halwani R, Qaisar R, Ahmad F. SARS-CoV-2 infection- induced growth factors play differential roles in COVID-19 pathogenesis. Life Sci 2022;304:120703. [PMID: 35700841 DOI: 10.1016/j.lfs.2022.120703] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Bonafè M, Olivieri F. Inflammaing: the lesson of COVID-19 pandemic. Mech Ageing Dev 2022;:111685. [PMID: 35595122 DOI: 10.1016/j.mad.2022.111685] [Reference Citation Analysis]
5 Gupta A, Al-Tamimi AO, Halwani R, Alsaidi H, Kannan M, Ahmad F. Lipocalin-2, S100A8/A9, and cystatin C: Potential predictive biomarkers of cardiovascular complications in COVID-19. Exp Biol Med (Maywood) 2022;:15353702221091990. [PMID: 35466734 DOI: 10.1177/15353702221091990] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Gupta A, Marzook H, Ahmad F. Comorbidities and clinical complications associated with SARS-CoV-2 infection: an overview. Clin Exp Med 2022. [PMID: 35362771 DOI: 10.1007/s10238-022-00821-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
7 Al-Tamimi AO, Yusuf AM, Jayakumar MN, Ansari AW, Elhassan M, AbdulKarim F, Kannan M, Halwani R, Ahmad F. SARS-CoV-2 infection induces soluble platelet activation markers and PAI-1 in the early moderate stage of COVID-19. Int J Lab Hematol 2022. [PMID: 35266284 DOI: 10.1111/ijlh.13829] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
8 Giuliani A, Matacchione G, Ramini D, Di Rosa M, Bonfigli AR, Sabbatinelli J, Monsurrò V, Recchioni R, Marcheselli F, Marchegiani F, Piacenza F, Cardelli M, Galeazzi R, Pomponio G, Ferrarini A, Gabrielli A, Svegliati Baroni S, Moretti M, Sarzani R, Giordano P, Cherubini A, Corsonello A, Antonicelli R, Procopio AD, Ferracin M, Bonafè M, Lattanzio F, Olivieri F. Circulating miR-320b and miR-483-5p levels are associated with COVID-19 in-hospital mortality. Mechanisms of Ageing and Development 2022;202:111636. [DOI: 10.1016/j.mad.2022.111636] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
9 Guest PC, Rahmoune H. Liquid Chromatography-Mass Spectrometry Analysis of Peripheral Blood Mononuclear Cells from SARS-CoV-2 Infected Patients. Multiplex Biomarker Techniques 2022. [DOI: 10.1007/978-1-0716-2395-4_15] [Reference Citation Analysis]
10 Barale C, Melchionda E, Morotti A, Russo I. Prothrombotic Phenotype in COVID-19: Focus on Platelets. Int J Mol Sci 2021;22:13638. [PMID: 34948438 DOI: 10.3390/ijms222413638] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
11 Zhou X, Cheng Z, Hu Y. COVID-19 and Venous Thromboembolism: From Pathological Mechanisms to Clinical Management. J Pers Med 2021;11:1328. [PMID: 34945800 DOI: 10.3390/jpm11121328] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Al-tamimi AO, Yusuf AM, Jayakumar MN, Ansari AW, Elhassan M, Abdulkarim F, Kannan M, Halwani R, Ahmad F. SARS-CoV-2 infection induces soluble platelet activation markers and PAI-1 in the early moderate stage of COVID-19.. [DOI: 10.1101/2021.08.23.457378] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]